Our Mission

 

PAION’s mission is to be a leading specialty pharmaceutical company in the fields of anesthesia and critical care by bringing novel products to market to benefit patients, doctors and other stakeholders in healthcare.

H1 2021

Teleconference & webcast

23. August 2021

Replay

news

01/07/2022

​​​​​​​PAION ASSIGNS CHINESE REMIMAZOLAM PATENTS AND SELLS RELATED FUTURE...

PAION AG / Key word(s): Contract ​​​​​​​PAION ASSIGNS CHINESE...

Read more
12/31/2021

PAION SUBMITS EXTENSION APPLICATION OF MARKETING AUTHORIZATION FOR REMIMAZOLAM...

DGAP-News: PAION AG / Key word(s): Regulatory Admission...

Read more
11/10/2021

​​​​​​​PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST NINE MONTHS OF...

DGAP-News: PAION AG / Key word(s): Quarterly / Interim Statement...

Read more
To the newsroom

PAION Chart

Load Chart

I consent to the display of external content. This enables personal data to be transmitted to third-party platforms. Read more about our privacy policy.

 

Visit us on LinkedIn!
LinkedIn